Portfolio Company · Operating Co.

Carlsmed

Med-Tech

backed byUS Venture Partners and Wavemaker 360 Health

CurrentMed-Tech

Carlsmed

a portfolio company of

US Venture Partners

Status on record: Current

PE Firm Index

Carlsmed

a portfolio company of

Wavemaker 360 Health

Status on record: Current

PE Firm Index

Who owns Carlsmed?

Carlsmed is listed on the portfolio pages of US Venture Partners (portfolio page) and Wavemaker 360 Health (portfolio page). US Venture Partners and Wavemaker 360 Health list it as current.

Company Snapshot

Carlsmed is a Med-Tech company. Its owner on record, US Venture Partners, is a firm. US Venture Partners lists 144 companies in the index, 9 of them in Med-Tech. Also backed by Wavemaker 360 Health.

SectorMed-Tech

Backed byUS Venture Partners and Wavemaker 360 Health

Ownership statusCurrent

WebsiteNot on record

About the owner

US Venture Partners

Companies in the index: 144

Venture capital firm investing in enterprise software and healthcare.

Read the US Venture Partners profile

Wavemaker 360 Health

Companies in the index: 62

Healthcare-focused early-stage venture capital firm.

Read the Wavemaker 360 Health profile

Questions about Carlsmed

Who owns Carlsmed?

Carlsmed is listed on the portfolio pages of US Venture Partners (portfolio page) and Wavemaker 360 Health (portfolio page). US Venture Partners and Wavemaker 360 Health list it as current.

What sector is Carlsmed in?

Carlsmed is in Med-Tech. Classified from the owner's portfolio label.

What else does US Venture Partners own in Med-Tech?

US Venture Partners lists 8 other Med-Tech companies in the index, including AImbient, Cagent Vascular, Carrot, HighLife Medical and Luminopia.

Sources

US Venture Partners' page on Carlsmed
Wavemaker 360 Health's page on Carlsmed
US Venture Partners
https://www.usvp.com/portfolio
Wavemaker 360 Health
https://www.wavemaker360.com/portfolio

This profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with Carlsmed and does not provide investment advice.

Other portfolio companies of US Venture Partners

6 of 143 shown

See the full US Venture Partners portfolio.

Other portfolio companies of Wavemaker 360 Health

6 of 61 shown

See the full Wavemaker 360 Health portfolio.

Other Med-Tech companies held by US Venture Partners

AImbient Cagent Vascular

Carrot

HighLife Medical Luminopia

Mobia Medical

Other Med-Tech companies held by Wavemaker 360 Health

32co Advocatia Airpay Alertive Arcuity AI Astromind

Other Med-Tech portfolio companies

3P Biopharmaceuticals

via Marlin Equity Partners

A-S Medication Solutions (ASMS)

via Warburg Pincus

Browse PE-backed companies.

Is this your company?

Claiming is free and reviewed by hand. Correct facts and add your team.

Claim this profile Suggest a correction

Ownership

Backed by

US Venture Partners

Status: Current

Backed by

Wavemaker 360 Health

Status: Current

For PE-backed companies

DevriX

DevriX runs the websites, integrations and data that bring in revenue, as one accountable engineering and operations team, through acquisitions and exit.

Where DevriX helps

Value creation through the holdRevenue, data, web and AI run as one operating cadence, tied to EBITDA.Add-ons and carve-outsConsolidate or separate platforms and unify reporting after a deal.Exit readinessFind the technology and data issues a buyer's diligence would raise, before it does.

Send DevriX a short brief

A short form on devrix.com. No call to book.

Disclosure: PE Firm Index is maintained by Mario Peshev, who founded and runs DevriX. DevriX listing

Weekly PE M&A and market research, by email

The Growth Shuttle Insider is Mario Peshev's weekly newsletter for PE owners and operators. Each issue carries the week's private equity deals from this index, market data and research, and an essay from Mario.

Free. One email a week. Unsubscribe from any issue. Your address goes to beehiiv, the service that sends the Insider.

Research

The 2027 Digital Value Creation Baseline

1,407 PE-backed companies from 179 sponsors, measured from public sources in October 2026. 15% of service and product companies have the full path from search to CRM.

Read the research

Research by Growth Shuttle and DevriX.